Heart failure & cardiomyopathiesCohort study

Pregnancy-Associated Cardiomyopathy and Long-Term Cardiac Phenotype in Women With Truncating Titin Variants

JACC AdvPublished

  • ambispective cohort study
  • consecutive TTNtv genotype-positive women, regardless of phenotype

Authors' conclusion

In this TTNtv-positive cohort, PAC incidence appeared higher than reported PPCM rates in the general European population. However, pregnancy was well tolerated and was not associated with adverse long-term cardiac remodeling.

Study context

Population
TTNtv genotype-positive women with ≥1 cardiological evaluationTTNtv-positive women (17% probands), 78 with prior pregnancies
Participants
107 women
Exposure
parous vs nulliparous

Main finding

As reported in the abstract

Live births

206 pregnancies among 78 women with prior pregnancies resulted in live births

167 (81%)

Observational data: associations, not effects.

Further findings

Pregnancy-associated cardiomyopathy (PAC)

PAC in live births
3 of 167
PAC in women
3 of 76
cumulative incidence per live birth
1.8%
cumulative incidence per woman
3.9%
All affected women recovered completely with medical therapy

Maternal and fetal adverse events in remaining pregnancies

Remaining pregnancies were largely uncomplicated, without increased maternal or fetal adverse events

Arrhythmic burden, cardiac function, ventricular dimensions · median of 18 years (IQR: 9-31) after pregnancy

no differences were observed between parous and nulliparous women

Original publication

Pregnancy-Associated Cardiomyopathy and Long-Term Cardiac Phenotype in Women With Truncating Titin Variants. JACC Adv. Published 3 June 2026. doi:10.1016/j.jacadv.2026.102857

Summarised from the published abstract; every number is checked against it